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Abstract: Japanese encephalitis (JE), a mosquito-borne viral disease, is endemic to the 
entire east and southeast Asia, and some other parts of the world. Currently, there is no 
effective therapeutic available for JE; therefore, finding the effective antiviral agent against 
JEV replication is crucial. In the present study, the in vitro antiviral activity of baicalein 
and quercetin, two purportedly antiviral bioflavonoids, was evaluated against Japanese 
encephalitis virus (JEV) replication in Vero cells. Anti-JEV activities of these compounds 
were examined on different stages of JEV replication cycle. The effects of the compounds 
on virus replication were determined by foci forming unit reduction assay (FFURA) and 
quantitative RT-PCR. Baicalein showed potent antiviral activity with IC50 = 14.28 µg/mL 
when it was introduced to the Vero cells after adsorption of JEV. Quercetin exhibited weak 
anti-JEV effects with IC50 = 212.1 µg/mL when the JEV infected cells were treated with 
the compound after virus adsorption. However, baicalein exhibited significant effect 
against JEV adsorption with IC50 = 7.27 µg/mL while quercetin did not show any  
anti-adsorption activity. Baicalein also exhibited direct extracellular virucidal activity on 
JEV with IC50 = 3.44 µg/mL. However, results of quantitative RT-PCR experiments 
confirmed the findings from FFURA. This study demonstrated that baicalein should be 
considered as an appropriate candidate for further investigations, such as the study of 
molecular and cellular mechanism(s) of action and in vivo evaluation for the development 
of an effective antiviral compound against Japanese encephalitis virus. 
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1. Introduction 
The Japanese encephalitis virus (JEV) is an arthropod-borne virus emerging from the Flaviviridae 
family. It is one of the most important causative agents for viral encephalitis in human that can cause 
symptoms ranging from febrile to mortal illnesses notably in children with 30,000–50,000 cases 
around the world annually. JEV infection is endemic in eastern and southern Asia including in Nepal, 
Indonesia, China, Thailand, Australia, Sapian Island, Pakistan and the Torres Strait [1–4]. The fatality 
rate of JEV infection is estimated at about 30%, with life-long neurological impairments and sequels 
among half of the survivors [5]. Japanese encephalitis virus is an enveloped virus with a positive sense 
single stranded RNA of 11 kb in length. Its genome formed a single long open reading frame (ORF) 
flanked by the 5'-UTR and 3'-UTR. The ORF is translated into a polyprotein, which is processed by 
viral and cellular proteases to yield three structural proteins called capsid (C), pre-membrane (prM), 
envelope (E), and seven non-structural (NS) proteins namely NS1, NS2 A/B, NS3, NS4 A/B and NS5 [6]. 
There are still concerns of efficacy, long term safety and cost for all the current available vaccines 
resulting in a high percentage of unvaccinated population in endemic regions, which translates as many 
cases of JE in these regions [7]. Thus, there is still a need to find effective antiviral against JEV [8]. 
There have been efforts to find effective antiviral substance among the natural compounds such as 
plant or algal derived compounds [9,10]. Recently, in vitro anti-JEV activities of two different types of 
bioflavonoids namely kaempferol and daidzin were evaluated and it was shown that kaempferol is 
more effective against JEV replication compared to daidzin [11]. Compounds from natural resources 
are regarded as possible alternatives as they may show low side effects and easily accessible from 
nature. Among the natural compounds, flavonoids driven from fruits, roots, nuts, seeds, bark, steams 
and flowers of plants have been investigated to display numerous possible biological benefits [12–14]. 
Baicalein a flavonoid among the flavones subgroup has exhibited antiviral activities against a number 
of viruses including herpes viruses, some human adenoviruses and respiratory syncytial virus [15,16]. 
In addition, quercetin a flavonoid from flavonol subgroup has showed antiviral activities against 
viruses such as influenza virus, some herpes viruses, porcine epidemic diarrhea virus and some types 
of human adenoviruses [15–20]. We have recently reported the inhibitory effect of quercetin against  
in vitro replication of dengue virus [21]. Here we evaluate the in vitro antiviral activity of baicalein 
and quercetin against different stages of JEV replication cycle. 
2. Results 
2.1. Cytotoxicity of Bioflavonoids 
A MTT(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay was used to 
determine the cytotoxicity effect of baicalein and quercetin on Vero cells in which the half maximal 
cytotoxic concentration (CC50) value of each compound was calculated. Vero cells were treated by 
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bioflavonoids for two days, which was the same duration as in the antiviral activity assay. Results 
illustrate a higher cytotoxic value of CC50 = 115.2 ± 0.2 µg/mL for baicalein compared to quercetin 
with CC50 = 256.5 ± 0.17 µg/mL. Treated cells with vehicle control, 1% DMSO did not show any 
cytotoxicity against Vero cells.  
2.2. Antiviral Activity of Baicalein and Quercetin against JEV 
Baicalein and quercetin were examined for the potential antiviral effects, (i) for their prophylactic 
activity, (ii) for their intracellular antiviral activity after virus adsorption, (iii) against virus adsorption 
to the cells and (iv) adding directly to the virus suspension in order to examine the compounds’ direct 
virucidal effect. 
Results of prophylactic treatment with the tested bioflavonoids showed that 25 µg/mL of baicalein 
and quercetin could decrease the copy number of JEV RNA 34% ± 2.3% and 5.45% ± 0.54% 
respectively when compared to the non-treated cells (Figure 1B). The half maximal concentration 
(IC50) value for baicalein based on the data from FFURA was 84.18 ± 1.08 µg/mL (Figure 1A). 
Quercetin did not exhibit a significant prophylactic activity, therefore its IC50 value was not considered. 
Figure 1. Evaluation of the prophylactic effects of baicalein and quercetin on Japanese 
encephalitis virus (JEV) in vitro replication. Foci forming unit reduction assay was used to 
evaluate the prophylactic effects (A) and the respective JEV RNA copies were quantified 
using qRT-PCR (B). All experiments were performed in triplicates. Data were plotted 
using Graph Pad Prism Version 5 (Graph Pad Software Inc., San Diego, CA, USA, 2005). 
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Indeed, baicalein showed anti-adsorption activity against JEV with IC50 = 7.27 ± 1.08 µg/mL 
(Figure 2A). In addition, JEV RNA copy number decreased 77.3% ± 2.4% in the presence of  
25 µg/mL of baicalein during the viral adsorption period (Figure 2B). There was no significant  
anti-adsorption activity against JEV by quercetin and the JEV copy number decreased 8.46% ± 0.64% 
in the presence of 25 µg/mL of that compound (Figure 2B). 
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Figure 2. Effects of baicalein and quercetin against JEV adsorption to the Vero cells. Foci 
forming unit reduction assay was used to evaluate the antiviral activities (A) and the 
respective JEV RNA copies were quantified using qRT-PCR (B); All experiments were 
performed in triplicates. Data were plotted using Graph Pad Prism Version 5. 
0 20 40 60 80 100
0
20
40
60
80
100
Baicalein
Quercetin
Concentration(µg/ml)
(A)
Fo
ci
 re
du
ct
io
n(
%
)
0.0
0
12
.50
25
.00
50
.00
10
0.0
0
0.0
0
12
.50
25
.00
50
.00
10
0.0
0
0
20
40
60
80
100
Quercetin
Baicalein
Concentration(µg/ml)
(B)
RN
A 
co
py
 n
um
be
r r
ed
uc
tio
n 
(%
)
 
In post adsorption assay, baicalein exhibited potent antiviral activity against JEV with  
IC50 = 5.8 ± 1.09 µg/mL (Figure 3A). The copy number of viral RNA was decreased 68.46% ± 1.19% 
when the infected cells were treated with 25 µg/mL (Figure 3B). The IC50 for quercetin at this phase of 
experiment was 212.1 ± 0.9 µg/mL but it is too closed to the CC50 value for quercetin. The copy number 
of JEV RNA decreased 9.1% ± 0.2% in presence of 50 µg/mL of that bioflavonoid (Figure 3B). 
Figure 3. Antiviral activity of baicalein and quercetin against JEV intracellular replication. 
Foci forming unit reduction assay was used to evaluate the antiviral activities (A) and the 
respective JEV RNA copies were quantified using qRT-PCR (B). All experiments were 
performed in triplicates. Data were plotted using Graph Pad Prism Version 5. 
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Baicalein showed direct virucidal activity with IC50 = 3.44 ± 1.04 µg/mL (Figure 4A) against JEV 
particles. However, qRT-PCR analysis showed that 25 µg/mL of baicalein decreased the DENV-2 
RNA production 78.7% ± 1.2% (Figure 4B). Meanwhile, quercetin did not exhibit any significant 
direct extracellular activity JEV (Figure 4A) and 25 µg/mL of that bioflavonoid could decrease the 
JEV RNA copy number only for 3.6% ± 0.5% (Figure 4B).  
Figure 4. Direct virucidal activity of baicalein and quercetin against JEV. Foci forming 
unit reduction assay was used to determine the direct virucidal activities of the compounds 
against extracellular JEV (A) and the respective JEV RNA copies were quantified using 
qRT-PCR (B). All experiments were performed in triplicates. Data were plotted using 
Graph Pad Prism Version 5. 
0 20 40 60 80 100
0
20
40
60
80
100
Baicalein
Quercetin
Concentration(µg/ml)
(A)
Fo
ci
 re
du
ct
io
n(
%
)
0.0
0
12
.50
25
.00
50
.00
10
0.0
0
0.0
0
12
.50
25
.00
50
.00
10
0.0
0
0
20
40
60
80
100
Quercetin
Baicalein
Concentration(µg mL-1)
(b)
RN
A 
co
py
 n
um
be
r r
ed
uc
tio
n 
(%
)
 
3. Discussion 
Bioflavonoids are phenolic compounds that are generally found in plants. Several investigations 
have shown their beneficial effects on human health [22,23]. Numerous studies have shown that some 
flavonoids exhibited antiviral effects against a number of viruses including dengue virus, hepatitis B 
virus, human cytomegalovirus and few others [15–18,21]. In one study, it was demonstrated that 
baicalein was the most effective antiviral against cytomegalovirus compared to the other tested 
flavonoids such as quercetin, apigenin, naringenin, daidzein, luteolin and some other flavonoids [15]. 
Indeed, it was demonstrated that baicalein increased the in vitro and in vivo antiviral activity of 
ribavirin against influenza virus significantly [24]. Recently, through theantiviral activity of 
kaempferol and daidzin, two types of flavonoids against Japanese encephalitis virus were reported [11]. 
In the present study we also have demonstrated that baicalein exhibited potent in vitro anti-JEV effects 
at all different stages of JEV infection compared to the quercetin. The selectivity indices (SI) for 
baicalein for all stages were significantly higher than that of quercetin. Baicalein exhibited significant 
direct virucidal activity (SI = 33.4) as well as intracellular anti-JEV activity (SI = 15.8) and anti-adsorption 
activity (SI = 15.8) but its prophylactic activity was not significant (SI = 1.3). On the other hand, 
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quercetin exhibited anti-JEV activity only when used against JEV adsorption to the cells (SI = 1.2). It 
was also demonstrated that the production of JEV-RNA decreased more than 17% in the presence of 
50 µg/mL of quercetin when it was used after virus adsorption (Figure 3B). Similar to our previous 
findings with the anti-dengue activity of quercetin [21] there was no significant anti-JEV effect when it 
was tested for its prophylactic, anti-adsorption or its direct virucidal activity against JEV. 
The mechanism(s) conferring the antiviral properties of baicalein against JEV is unknown. 
Regarding the potent virucidal activity of baicalein against extracellular JEV particles with SI = 33.4 
might be one of the main mechanisms that can explain anti-JEV activity of baicalein. A possible 
mechanism, which might explain the prophylactic activity of baicalein against JEV replication, is 
about the accumulation of the compound in the cells during the treatment. However, prevention of virus 
adsorption to the cells is another possibility that might lead to the inhibition of virus entry to the cells.  
Another possibility for mechanism of action for intracellular anti-JEV activity is binding of 
baicalein to the viral RNA. This possibility was shown in a recent study for two other flavonoids, 
kaempferol and daidzin using the JEV frame shift RNA [11]. Results from qRT-PCR indicate that 
significant reduction of JEV RNA copy number is consistent with inhibition of JEV replication and/or 
RNA synthesis together with transcription. 
The other possible mechanism of action for baicalein includes interaction with JEV structural 
and/or non-structural protein(s). It has previously been shown that baicalein affects Sendai virus 
replication through inhibition of virus hemagglutinin-neuraminidase activity [13]. Other studies have 
also shown that baicalein binds to HIV-1 integrase and reverse transcriptase enzymes [25,26]. These 
findings suggest that baicalein can bind to a number of viral enzymes important for their replication. 
On the other hand, quercetin a flavonoid with reported antiviral activity against hepatitis C virus 
(HCV), through binding and inactivating viral NS3 protease [27] did not show a significant anti-JEV 
activity in our study. In contrast with baicalein, which affected JEV adsorption and intracellular 
replication, quercetin showed no similar effects. Moreover, baicalein showed potent virucidal activity 
against extracellular viruses where quercetin did not exhibit the same effect. These findings are similar 
to our earlier experiments and findings on the effects of quercetin against dengue virus adsorption to 
the cells [21]. Quercetin might be considered as an anti-JEV compound upon further modifications to 
improve its anti-JEV effects. This possibility for influenza virus has been shown in one study that 
isoquercetin, a derivative of quercetin is more effective against influenza virus compared to quercetin [20]. 
In all our experiments, we showed that 0.5% of DMSO, the solvent used for our tested 
bioflavonoids did not exhibit any antiviral activity against JEV and this rule out any probable antiviral 
activity from DMSO. 
4. Experimental Section  
4.1. Bioflavonoids 
Two types of bioflavonoid, quercetin (Sigma-Aldrich, St. Louis, MO, USA) and baicalein (Indofine 
Chemical Co. Inc., Hillsborough, NJ, USA) were evaluated for their potential antiviral activity against 
Japanese encephalitis virus. Dimethyl sulfoxide (DMSO) (Sigma-Aldrich, St. Louis, MO, USA) was 
used as a proper solvent to prepare the compounds’ stock solution (20 mg/mL). The prepared stock 
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solutions were stored at −20 °C. Stock solution was diluted using cell culture medium and sterilized by 
syringe filter with 0.2 micron pore size (Millipore, Billerica, MA, USA). 
4.2. Cell and Virus 
Vero cell line derived from the kidney of African green monkey was used in this study. The cell line 
was maintained and propagated in Eagle’s Minimum Essential Medium (EMEM) (Gibco, New York, 
NY, USA) containing 10% fetal bovine serum (Gibco, New York, NY, USA). Cultured cells were 
incubated at 37 °C in 5% CO2 humidified chamber. At the time of virus propagation and antiviral 
experiments, the serum concentration was reduced to 2%. Japanese encephalitis virus (JEV) (Accession 
Number: HE861351) was propagated and harvested after cytopathic effects (CPE) presentation four 
days post-infection. Viral stock was titred using foci forming assay (FFA) and stored at −70 °C. 
4.3. In Vitro Cytotoxicity Assay 
Cytotoxicity assays of baicalein and quercetin against Vero cells were performed using the MTT 
assay method. Briefly, a confluent monolayer of Vero cell line was prepared in 96-well microplate and 
treated by different concentrations of each compound in triplicates. The treated cells were incubated 
for two days at 37 °C that is consistent with the incubation period for anti-JEV activity assay. After 
two days treatment, the MTT assay was performed strictly according to the manufacturer’s 
recommendation and as described earlier [14]. Dose-response curve was plotted using Graph Pad 
Prism 5 (Graph Pad Software Inc., San Diego, CA, USA, 2005) and the half maximal cytotoxic 
concentration (CC50) was determined from the plot. 
4.4. Foci Forming Reduction Assay (FFURA) 
Antiviral activities of baicalein and quercetin were evaluated by measuring the reduction in the 
number of viral foci, which was formed following treatments. Briefly, confluent monolayers of Vero 
cells were prepared in 24-well cell culture microplate. Infected cell monolyaers were treated using 
different procedures that will be described later and overlaid with 1.5% CMC containing EMEM with 
2% FBS and incubated at 37 °C in 5% CO2 humidified chamber for two days. Viral foci formed were 
stained using JEV monoclonal antibody (Pierce, Rockford, IL, USA) and goat anti-rabbit IgG 
conjugated with horse-radish peroxidase (HRP). Foci were counted under a stereomicroscope and 
expressed as Foci-Forming-Unit (FFU).  
Reduction in number of viral foci (RF%) compared against the mock treated controls was calculated 
as follows: RF (%) = (C − T) × 100/C 
Where, C is the mean of the number of foci for the mock treated control well infected with JEV and 
T is the mean of the number of foci formed in the JEV infected cell cultures. 
4.5. Assays of Antiviral Activity 
Antiviral assays were performed as described previously [21]. The prophylactic effects of the 
compounds on JEV replication was evaluated by adding the different concentrations of each compound 
separately to the Vero monolayer cells in triplicates, 5 h prior to JEV infection. Cells were then washed 
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using sterile PBS to remove the flavonoids and infected with JEV to give an estimated infection of  
200 FFU (0.01 MOI) per well and kept at 37 °C for 1 h. The cells were then washed with PBS to 
eliminate unabsorbed viruses, overlaid by 1.5 CMC containing EMEM with 2% and incubated for 
another two days. 
The antiviral activity of the compounds against intracellular JEV replication was evaluated by 
inoculating of 200 FFU of virus (0.01 MOI) to each well in triplicates. After 1 h incubation at 37 °C 
for virus adsorption, the cells were washed with PBS and different concentrations of each compound 
that prepared in 1.5% CMC containing EMEM with 2% FBS were added to the cells, followed by  
two days of incubation at 37 °C.  
To determine the effect of bioflavonoids against adsorption of JEV to the host cells, Vero cells at 
80% confluence were infected with 200 FFU of JEV in the presence or absence of different 
concentrations of each compound. After washing, the infected cells were overlaid by 1.5% CMC 
containing EMEM with 2% FBS and incubated at 37 °C for two days. 
4.6. Direct Virucidal Activity Assay 
Extracellular effects of the baicalein and quercetin against JEV particles were investigated by 
incubating the JEV suspension containing 105 FFU (5 MOI) with an equal volume of the different 
concentrations of each compound for 2 h at 37 °C. Then, Vero cells were infected with the 1000 fold 
diluted treated viral suspension in triplicates. After 1 h adsorption at 37 °C, cells were washed twice 
with PBS in order to remove unattached viruses. Cells were overlaid by 1.5% CMC containing EMEM 
with 2% FBS and incubated at 37 °C for two days. 
4.7. Quantitative RT-PCR (qRT-PCR) 
Quantitative RT-PCR was performed to evaluate the effects of baicalein and quercetin on JEV 
replication by quantifying the JEV RNA copy number based on a method described previously with 
some modifications [25]. Briefly, intracellular JEV RNAs were harvested from the JEV-infected Vero 
cells. Viral RNA was extracted using RNA extraction kits (Qiagen, Hilden, Germany). Quantitative 
RT-PCR assay was performed using the SensiMix SYBR green reagent (Quantace, Watford, UK)  
in a reaction mix consisting of 7.4 µL of ddH2O, 10 µL of 2× SensiMix One-Step,  
0.4 µL of 50× SYBR Green solution, 10 units of RNAse Inhibitor, 50 pmol of forward  
5'-AGAGCGGGGAAAAAGGTCAT-3' and reverse 5'-CTTCACGCTCTTCCTACAGT-3' JEV 
amplification primers [28,29]. All samples were assayed in triplicates. The amplifications were done 
on the StepOnePlus™ Real-Time PCR System (Applied Biosystems, Foster City, CA, USA) with the 
following thermal conditions: reverse transcription at 50 °C for 30 min, initial denaturation at 95 °C 
for 10 min, followed by 40 cycles of 95 °C for 5 s and 60 °C for 10 s. Melting curve analysis was 
subsequently performed at temperature from 60 °C to 98 °C to verify the assay specificity. For 
absolute quantitation of the viral RNA, a standard curve was established with a serially diluted in vitro 
transcribed RNA of JEV with known copy number. 
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4.8. Statistical Analysis 
Graph Pad Prism for Windows, version 5 (Graph Pad Software Inc., San Diego, CA, USA, 2005) 
was used to calculate half maximal cytotoxic concentration (CC50). The same software was used to 
calculate half maximal inhibitory concentration (IC50) values of the tested compounds by analyzing the 
data through the non-linear regression analysis. Selectivity Index value (SI) was determined as the 
ratio of CC50 to IC50 for each compound. 
5. Conclusions  
In summary, our study demonstrates that baicalein as a flavonoid possesses a series of significant 
antiviral activities against the different stages of in vitro JEV replication. Baicalein should be 
considered for further investigations as a possible novel antivirus against JEV. 
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